p53 codon 72 polymorphism and Hematological Cancer Risk: An Update Meta-Analysis
Author
Abstract
Suggested Citation
DOI: 10.1371/journal.pone.0045820
Download full text from publisher
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Lei Liu & Jinghua Jiao & Yu Wang & Dong Zhang & Jingyang Wu & Desheng Huang, 2014. "Lack of Association of the TP53BP1 Glu353Asp Polymorphism with Risk of Cancer: A Systematic Review and Meta-Analysis," PLOS ONE, Public Library of Science, vol. 9(3), pages 1-9, March.
More about this item
Keywords
“p53”; “codon 72” “polymorphism” and “leukemia”; or “lymphoma”; or “myeloma”; thirteen were identified as eligible articles in this meta-analysis for p53 arg72pro polymorphism (2; 731 cases and 7; 356 controls); including nine studies on leukemia (1; 266 cases and 4; 474 controls); three studies on lymphoma (1; 359 cases and 2; 652 controls); and one study on myeloma. the overall results suggested that p53 arg72pro polymorphism was not associated with hematological malignancies risk. in stratified analyses; significantly increased non-hodgkin lymphomas risk was found in p53 arg72pro polymorphism heterozygote model (arg/pro vs. arg/arg: or = 1.18; 95%ci: 1.02–1.35) and dominant model (arg/pro+pro/pro vs. arg/arg: or = 1.18; 95%ci: 1.03–1.34); but no significant association was found between leukemia risk and p53 arg72pro polymorphism. further studies showed no association between leukemia risk and p53 arg72pro polymorphism when stratified in subtypes of leukemias; ethnicities and sources of controls. conclusions/significance: this meta-analysis indicates that the p53 arg72pro polymorphism may contribute to susceptibility to non-hodgkin lymphomas.;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0045820. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.